ArticlePreventing chronic disease2025
Use of Cancer Screening Tests, United States, 2023.
Article in Preventing chronic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Value of Machine Learning Models for Cell-Free DNA-Based Multi-Cancer Early Detection: A Systematic Review and Meta-Analysis.Technology in cancer research & treatmentPooled it
- Race, ethnicity, and prior colorectal screening test use in CONFIRM colonoscopy vs fecal immunochemical testing trial participants.JNCI cancer spectrum · 2026Trial
- Some answers, more questions for multi-cancer early detection tests.Nature medicine · 2026Article
- Modeled Sojourn Time and Sensitivity for Detecting Preclinical Cancers Retrospectively by a Multicancer Early Detection Test.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026Article
- Comparative Analysis of Breast and Cervical Screening Adaptability at a Federally Qualified Health Center.Cancer prevention research (Philadelphia, Pa.) · 2026Article
- Article
- Colorectal cancer screening awareness among rural populations in Northern China.BMC public health · 2026Observational
- SNAP Participation and Cancer Screening for Adults With Food Insecurity.JAMA network open · 2026Article
- Factors associated with HCV coinfection and preferences for HCV screening services among people living with HIV/AIDS.BMC infectious diseases · 2026Article
- Article
- Correlates of Integrated Human Papillomavirus Vaccination and Cervical Cancer Screening Protection in U.S. Low-Income Women.Vaccines · 2026Article
- Feasibility of Using College Students to Increase Cancer Screening Behaviors Among Their Parents.International journal of environmental research and public health · 2026Article
- Test Ordering and Completion During Virtual vs In-Person Annual Visits.JAMA network open · 2026Article
- Sequential choice vs colonoscopy outreach for colorectal cancer screening: Design and rationale of a pragmatic randomized clinical trial.Contemporary clinical trials · 2026Article
- Patient navigation activities in a large community -based colorectal cancer screening program.BMC primary care · 2026Article
- Exploring current cancer screening practices and guidelines for adults under age 50 in the United States.Frontiers in public health · 2026Article
- Understanding barriers and facilitators to cervical cancer prevention among young Korean Women: A focus group interview study.PloS one · 2026Article
- Declining trends but persistent disparities in cervical cancer mortality in the United States, 1999-2023.Frontiers in public health · 2026Article
- Identifying gaps in women's preventive health services for women living with HIV in Vermont.Reproductive health · 2025Article
- Factors associated with mammogram and Papanicolaou testing among Mexican American older women.Women's health (London, England)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The objective of this analysis was to provide national estimates for use of breast, cervical, and colorectal cancer (CRC) screening tests, including for the recently expanded CRC screening age group (ages 45-75 y). Methods: We used data from the 2023 National Health Interview Survey to estimate proportions of screening-eligible adults up to date with breast (women aged 50-74 y), cervical (women aged 21-65 y), and CRC screening (adults aged 45-75 y). We compared breast and CRC estimates age-standardized to the 2000 US standard population to Healthy People 2030 (HP2030) targets. Age-standardized estimates of breast, cervical, and CRC test use were compared with estimates from 2019 (breast, cervical) and 2021 (breast, cervical, CRC). Results: In 2023, estimated percentages of adults up to date were 80.0% (95% CI, 78.7%-81.2%), 75.4% (95% CI, 74.1%-76.6%), and 67.4% (95% CI, 66.3%-68.4%), for breast, cervical, and CRC screening test use, respectively. CRC test use was lower among those aged 45 to 49 years than those aged 50 to 75 years (37.1% vs 73.4%, P < .001). Mammography use approximated the HP2030 target. CRC test use was below the target. Breast, cervical, and CRC screening test use varied with almost all sociodemographic characteristics and health care access, financial hardship, and other barriers examined. Mammography estimates were somewhat higher and cervical test estimates were lower in 2023 than in 2019 and 2021. CRC test use was lower in 2023 than 2021. Conclusion: In 2023, most adults were up to date with breast, cervical, and CRC screening test use; however, 1 in 3 adults (CRC) to 1 in 5 adults (breast) were not. Future monitoring can help determine if changes continue and track progress toward national targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.